Sucampo
Sucampo develops and commercializes therapeutic compounds for the treatment of genetic disorders and orphan diseases.
Business Model:
Revenue: $250.5M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Sucampo Information
Sucampo was acquired by
Mallinckrodt.
The acquisition happend on 2017-12-26.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 805 King Farm Blvd
City: Rockville
State: MD
Zip: 20850
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$293M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sucampo develops and commercializes therapeutic compounds for the treatment of genetic disorders and orphan diseases.
Contact Phone:
+13019613400
Contact Email:
Sucampo went public on 8/3/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/3/2007
IPO Valuation:
$173M
Ticker Symbol:
SCMP
IPO Price:
$11.5/share
Amount Raised:
$43M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
